Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME).

Jeff UngerDale C AllisonMargit KaltoftKavitha LakkoleJayant K PandaChethana RameshMehmet SarginElena SmolyarchukMelissa TwineBenjamin WolthersGizem YarimbasMarouan Zoghbinull null

Published in: Diabetes, obesity & metabolism (2021)

Glycaemic control was better maintained with liraglutide versus OAD, supporting liraglutide use when intensifying therapy in primary care patients with T2D.

Keyphrases

primary care
type diabetes
general practice
mesenchymal stem cells
bone marrow